NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Eravacycline

Last Revision: July 20, 2020.

Estimated reading time: 1 minute

CASRN: 1207283-85-9

image 162108766 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the use of eravacycline during breastfeeding. The manufacturer states that breastfeeding is not recommended during treatment and for 4 days after the last dose. However, available literature indicates that there is not likely to be harm in short-term use of a eravacycline during lactation because the drug is 79 to 90% bound to plasma proteins, so milk levels are likely low and absorption by the infant is likely inhibited by the calcium in breastmilk. Short-term use of eravacycline acceptable in nursing mothers. If an infant is breastfed, monitor the infant for possible effects on the gastrointestinal flora, such as diarrhea, candidiasis (e.g., thrush, diaper rash) or rarely, blood in the stool indicating possible antibiotic-associated colitis. As a theoretical precaution, avoid prolonged or repeat courses during nursing.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Eravacycline

CAS Registry Number

1207283-85-9

Drug Class

Breast Feeding

Lactation

Anti-Infective Agents

Antibacterial Agents

Tetracyclines

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Omadacycline[Drugs and Lactation Database (...]
    Review Omadacycline
    . Drugs and Lactation Database (LactMed). 2006
  • Review Tigecycline[Drugs and Lactation Database (...]
    Review Tigecycline
    . Drugs and Lactation Database (LactMed). 2006
  • Review Minocycline[Drugs and Lactation Database (...]
    Review Minocycline
    . Drugs and Lactation Database (LactMed). 2006
  • Review Tetracycline[Drugs and Lactation Database (...]
    Review Tetracycline
    . Drugs and Lactation Database (LactMed). 2006
  • Review Demeclocycline[Drugs and Lactation Database (...]
    Review Demeclocycline
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...